PhagePatch™ is a single‑use, battery‑free microneedle patch engineered for precise intradermal delivery. Its bacteriophage‑inspired geometry self‑orients on the skin and fires only under proper contact—reducing training burden and sharps risk.
Deliver fractional volumes directly to the dermis (≈300–700 µm) for efficient antigen presentation while stretching limited supply. The contact‑gated actuator supports consistent placement across users and settings, from clinics to field campaigns.
Micro‑volume delivery for peptides and biologics—such as allergen immunotherapy, dermatologic agents, and CGRP inhibitors—without syringes or batteries. Self‑orienting landing fins form a stable seal for predictable absorption and minimal discomfort.
Investigational device — availability depends on regulatory clearance. Information provided for partners, clinicians, and investors evaluating the platform.